DAVID CLEMENTS: Open Payments
NPI 1932574118 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 69 payments from 9 companies in 2025. Trend: 2023 $642 · 2024 $761 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 29 | $384 |
| Axsome Therapeutics, Inc. | 13 | $183 |
| ABBVIE INC. | 15 | $174 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| Lundbeck LLC | 3 | $55 |
| Corium, LLC | 2 | $48 |
| Alkermes, Inc. | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| Braeburn Inc. | 1 | $19 |
Products named: CAPLYTA, Auvelity, VRAYLAR, Jornay PM, REXULTI, Azstarys, ARISTADA, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
